Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Zila, a diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease, has appointed Wade Brooksby to its board of directors. Mr Brooksby will serve on the audit committee.
Subscribe to our email newsletter
The appointment increases the board to six members, five of whom are non-employee directors. Mr Brooksby is currently CFO of InNexus Biotechnical, a publicly traded drug development company. Previously, Mr Brooksby was CFO of Energy West, a publicly traded energy utility.
Mr Brooksby has earned a bachelor of science degree in accounting and a masters degree in accounting from Brigham Young University.
David Bethune, chairman and CEO of Zila, said: “Wade brings to Zila’s board of directors extensive operating experience gained as a senior executive for organizations of all sizes. His background adds depth to our already talented and diverse board. We welcome Wade and look forward to his guidance as we work toward achieving our long-term strategic goals.”